Search Results | Cancer Research | American Association for Cancer Research

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Abstract A039: Arginyltransferase Ate1 reduction drives prostate cancer metastasis

Michael D. Birnbaum, Ning Zhou, Kerry L. Burnstein, Fangliang Zhang

Cancer Res (2018) 78 (16_Supplement): A039.

DOI: https://doi.org/10.1158/1538-7445.PRCA2017-A039

Published: 14 August 2018

View article

Journal Articles

Abstract A050: Integrated system-level analyses define an androgen receptor variant oncogenic network for advanced prostate cancer

Fiorella Magani, Eric Bray, Maria Julia Martinez, Valeria Copello, Ning Zhao, Stephanie Peacock, David Wiley, Gennaro D’urso, Kerry L. Burnstein

Cancer Res (2018) 78 (16_Supplement): A050.

DOI: https://doi.org/10.1158/1538-7445.PRCA2017-A050

Published: 14 August 2018

View article

Journal Articles

Abstract 1314: A prostate cancer androgen receptor variant gene network with prognostic and therapeutic value identified using integrated systems analyses

Maria J. Martinez, Fiorella Magani, Eric R. Bray, Valeria Copello, Ning Zhao, Stephanie Peacock, David J. Wiley, Gennaro D'Urso, Kerry L. Burnstein

Cancer Res (2018) 78 (13_Supplement): 1314.

DOI: https://doi.org/10.1158/1538-7445.AM2018-1314

Published: 01 July 2018

View article

Journal Articles

Abstract 5479: Redox stress as a therapeutic Achilles heel in castration-resistant prostate cancer

Clara I. Troccoli, Govindi J. Samaranayake, Mai Q. Huynh, Karen Kage, Deukwoo Kwon, Yuguang Ban, Xi S. Chen, Enrique R. Zarco, Merce Jorda, Kerry L. Burnstein, Priyamvada Rai

Cancer Res (2017) 77 (13_Supplement): 5479.

DOI: https://doi.org/10.1158/1538-7445.AM2017-5479

Published: 01 July 2017

View article

Journal Articles

Abstract 5545: Integrated system-level analyses of androgen receptor variant networks to identify novel prostate cancer-relevant genes

Fiorella Magani, Eric R. Bray, Ning Zhao, Stephanie Peacock, Kerry L. Burnstein

Cancer Res (2017) 77 (13_Supplement): 5545.

DOI: https://doi.org/10.1158/1538-7445.AM2017-5545

Published: 01 July 2017

View article

Journal Articles

Abstract 1467: The miR-23b/-27b cluster decreases metastasis of aggressive prostate cancer

Meghan A. Rice, Reema Ishteiwy, Thirupandiyur Udayakumar, Derek Dykxhoorn, Kerry L. Burnstein

Cancer Res (2014) 74 (19_Supplement): 1467.

DOI: https://doi.org/10.1158/1538-7445.AM2014-1467

Published: 01 October 2014

View article

Journal Articles

Abstract 1069: Vav3 enhances androgen receptor splice variant activity and is critical for castration resistant prostate cancer growth and survival.

Stephanie Peacock, Cale D. Fahrenholtz, Kerry L. Burnstein

Cancer Res (2013) 73 (8_Supplement): 1069.

DOI: https://doi.org/10.1158/1538-7445.AM2013-1069

Published: 15 April 2013

View article

Journal Articles

Abstract 2148: Exploitation of androgen receptor splice variant signaling by guanine nucleotide exchange factor Vav3 in castration resistant prostate cancer

Stephanie Peacock, Cale Fahrenholtz, Kerry L. Burnstein

Cancer Res (2012) 72 (8_Supplement): 2148.

DOI: https://doi.org/10.1158/1538-7445.AM2012-2148

Published: 15 April 2012

View article

Journal Articles

Role of Rac1 GTPase hyperactivity in suppressing p21Cip1 levels and stimulating prostate cancer cell proliferation and tumor formation

Joanne M. Faysal, Selena Knight-Krajewski, Carol A. Maiorino, Wayne Balkan, Catherine F. Welsh, Kerry L. Burnstein

Cancer Res (2004) 64 (7_Supplement): 189.

Published: 01 April 2004

View article

Journal Articles

Vav3, a Rho GTPase guanine nucleotide exchange factor (GEF), is implicated in androgen independent prostate cancer progression

Leah S. Lyons, Kerry L. Burnstein

Cancer Res (2004) 64 (7_Supplement): 445–446.

Published: 01 April 2004

View article

Journal Articles

Correspondence re: S. E. Blutt, T. C. Polek, L. V. Stewart, M. W. Kattan, and N. L. Weigel, A Calcitriol Analogue, EB1089, Inhibits the Growth of LNCaP Tumors in Nude Mice. Cancer Res., 60: 779–782, 2000.

Gary G. Schwartz, Bal L. Lokeshwar, Kerry L. Burnstein

Cancer Res (2001) 61 (10): 4294.

Published: 01 May 2001

View article

NARROW

Abstract A039: Arginyltransferase Ate1 reduction drives prostate cancer metastasis

Abstract A050: Integrated system-level analyses define an androgen receptor variant oncogenic network for advanced prostate cancer

Abstract 1314: A prostate cancer androgen receptor variant gene network with prognostic and therapeutic value identified using integrated systems analyses

Abstract 5479: Redox stress as a therapeutic Achilles heel in castration-resistant prostate cancer

Abstract 5545: Integrated system-level analyses of androgen receptor variant networks to identify novel prostate cancer-relevant genes

Abstract 1467: The miR-23b/-27b cluster decreases metastasis of aggressive prostate cancer

Abstract 1069: Vav3 enhances androgen receptor splice variant activity and is critical for castration resistant prostate cancer growth and survival.

Abstract 2148: Exploitation of androgen receptor splice variant signaling by guanine nucleotide exchange factor Vav3 in castration resistant prostate cancer

Role of Rac1 GTPase hyperactivity in suppressing p21Cip1 levels and stimulating prostate cancer cell proliferation and tumor formation

Vav3, a Rho GTPase guanine nucleotide exchange factor (GEF), is implicated in androgen independent prostate cancer progression

Correspondence re: S. E. Blutt, T. C. Polek, L. V. Stewart, M. W. Kattan, and N. L. Weigel, A Calcitriol Analogue, EB1089, Inhibits the Growth of LNCaP Tumors in Nude Mice. Cancer Res., 60: 779–782, 2000.

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only